PheochromocytomaSymptoms, Doctors, Treatments, Advances & More
Learn About Pheochromocytoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Eren Berber is a General Surgeon practicing medicine in Cleveland, Ohio. Dr. Berber is rated as an Elite provider by MediFind in the treatment of Pheochromocytoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Pheochromocytoma, Thyroidectomy, and Parathyroidectomy. Dr. Berber is board certified in American Board Of Surgery, 2006.
University Of Colorado Hospital Authority
Lauren Fishbein is an Endocrinologist practicing medicine in Aurora, Colorado. Dr. Fishbein is rated as an Elite provider by MediFind in the treatment of Pheochromocytoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Pheochromocytoma, Multiple Endocrine Neoplasia Type 2, Neuroendocrine Tumor, and Adrenal Cancer.
Mayo Clinic-Rochester
Oksana Hamidi is an Endocrinologist practicing medicine in Virginia Beach, Virginia. Dr. Hamidi is rated as an Elite provider by MediFind in the treatment of Pheochromocytoma. She is also highly rated in 62 other conditions, according to our data. Her clinical expertise encompasses Cushing's syndrome, Addison's Disease, Pheochromocytoma, Hormone Replacement Therapy (HRT), and Liver Embolization.
Summary: Study in children and adolescents of 177Lu DOTATATE (Lutathera®) combined with the PARP inhibitor olaparib for treatment of recurrent or relapsed solid tumours expressing somatostatin receptors (SSTR) (LuPARPed)
Summary: The purpose of this research study is to find how active and safe 131 I-MIBG is in patients with resistant neuroblastoma, malignant pheochromocytoma and malignant paraganglioma.